Ultralife Corp. (NASDAQ: ULBI) reported Q2 EPS of $0.22, $0.09 better than the analyst estimate of $0.13. Revenue for the quarter came in at $43 million versus the consensus estimate of $43 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.